Participation in clinical trials has demonstrable effects on improved outcomes – they show us what works (and what doesn’t) in medicine. While fewer than 1 in 20 adult cancer patients in the U.S. have participated in a clinical trial, 60% of childhood cancer patients have participated. DOWNLOAD REPORT
Investment in R&D is the best way to ensure our nation is prepared to respond to health threats. New therapies do not come cheap. To go from concept to reality takes years of basic, clinical and translational science and research, all of which requires major financial investment, particularly from the private sector. DOWNLOAD REPORT
The Governor’s Office of Business and Economic Development (GO-Biz) serves as California’s leader for job growth and economic development efforts. GO-Biz created the California Business Portal listing a variety of incentive and financing programs to encourage business development in California. DOWNLOAD INFOGRAPHIC
California leads the world in life sciences innovation. Premier research institutions combine with a unique entrepreneurial spirit to develop new technologies and therapies, attract investors and push the state’s economy to greater heights. It’s critical that we protect this pioneering activity to continue bringing hope to patients everywhere. See the highlights from our 2019 California Life Sciences Industry Report.
The California Life Sciences Association (CLSA)—the statewide public policy organization representing California’s life sciences innovators, including medical device, diagnostic, biotechnology and pharmaceutical companies, research universities and private, non-profit institutes, and venture capital firms—commissioned a study from international health economics firm, Vital Transformation, to examine the impact that utilizing international reference pricing in Medicare Part D … Continue reading Report: Anticipated Effects of International Reference Pricing on California’s Biopharmaceutical Innovation Ecosystem
CLSA and Accenture are excited to announce The 2019 Digital Health Trends Report, the first comprehensive research report covering digital health specifically focused on California Life Sciences companies. This report highlights the real digital health opportunity for California Life Sciences companies and the key internal and external challenges to overcome. READ THE REPORT
The life sciences industry is thriving in California. Regions all over the state are reporting incredible progress that are making California’s biomedical sector one of the best in the nation. CLSA is pleased to release a member resource that showcases key employment, investment and other innovative trends in California’s top life sciences hotbeds. DOWNLOAD FACT … Continue reading Fact Sheets: California’s Top Life Sciences Clusters & Innovation Hotbeds
California Life Sciences Association (CLSA), the trade association representing California’s life sciences industry, and PwC US, are proud to release the 2019 California Life Sciences Industry Report. With over 350 data points, this 2019 Report provides a snapshot of California’s life sciences community, and how the world’s largest life sciences cluster remains a global hub for innovation, creating high-wage jobs, bringing new therapies and technologies to patients, and attracting significant investment from venture capitalists, the NIH and more.
According to Kaiser Health News, patients overpay for prescriptions 23% of the time. Check out CLSA’s infographic calling for more accountability of Pharmacy Benefit Managers (PBMs).
The 2018 Talent Integration: California Workforce Trends in the Life Science Industry report captures up-to-date information on the most critical current and projected talent needs of California’s innovative life science industry. Produced by the California Life Sciences Institute and the Biocom Institute, the report shows that California’s life science industry continues to be one of California’s leading employers, creating jobs for over 360,000 people.